Statement of Cash FlowsIndirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3		Dec. 31, 20Y2
Assets
Cash		$299,390		$279,780
Accounts receivable (net)		108,460		100,490
Inventories		306,150		297,510
Investments		0		115,260
Land		157,040		0
Equipment		337,800		263,040
Accumulated depreciationequipment		(79,080)		(70,930)
	Total assets	$1,129,760		$985,150
Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$204,490		$194,070
Accrued expenses payable (operating expenses)		20,340		25,610
Dividends payable		11,300		8,870
Common stock, $10 par		61,010		48,270
Paid-in capital: Excess of issue price over par-common stock		229,340		133,980
Retained earnings		603,280		574,350
	Total liabilities and stockholders equity	$1,129,760		$985,150

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

1. The investments were sold for $134,850 cash.
2. Equipment and land were acquired for cash.
3. There were no disposals of equipment during the year.
4. The common stock was issued for cash.
5. There was a $75,230 credit to Retained Earnings for net income.
6. There was a $46,300 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
	$
Adjustments to reconcile net income to net cash flow from operating activities:
Changes in current operating assets and liabilities:
Net cash flow from operating activities		$
Cash flows from investing activities:
	$
Net cash flow used for investing activities
Cash flows from financing activities:
	$
Net cash flow from financing activities
		$
Cash at the beginning of the year
Cash at the end of the year		$